LPL Financial LLC raised its holdings in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 66.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 87,446 shares of the company's stock after purchasing an additional 35,053 shares during the quarter. LPL Financial LLC owned 0.22% of Phibro Animal Health worth $1,836,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also recently made changes to their positions in the business. FMR LLC raised its holdings in shares of Phibro Animal Health by 22.7% in the 3rd quarter. FMR LLC now owns 39,310 shares of the company's stock worth $885,000 after purchasing an additional 7,270 shares during the period. Barclays PLC increased its position in Phibro Animal Health by 25.7% in the third quarter. Barclays PLC now owns 143,337 shares of the company's stock worth $3,228,000 after buying an additional 29,271 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Phibro Animal Health by 5.7% in the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company's stock valued at $11,430,000 after buying an additional 27,201 shares during the period. SG Americas Securities LLC lifted its position in shares of Phibro Animal Health by 7.4% during the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock valued at $276,000 after buying an additional 906 shares during the last quarter. Finally, Inspire Investing LLC bought a new position in shares of Phibro Animal Health during the 4th quarter worth $791,000. 99.34% of the stock is owned by hedge funds and other institutional investors.
Phibro Animal Health Price Performance
NASDAQ:PAHC traded up $0.46 during mid-day trading on Friday, hitting $17.29. 241,189 shares of the stock traded hands, compared to its average volume of 191,577. Phibro Animal Health Co. has a 12-month low of $12.30 and a 12-month high of $26.55. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The company has a market cap of $700.30 million, a PE ratio of 36.02, a price-to-earnings-growth ratio of 0.45 and a beta of 0.63. The business's 50-day moving average price is $21.46 and its 200 day moving average price is $22.30.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, analysts expect that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.
Phibro Animal Health Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th were given a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.78%. Phibro Animal Health's dividend payout ratio (DPR) is presently 100.00%.
Analyst Ratings Changes
Several research firms have commented on PAHC. Barclays upped their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a report on Monday, February 10th. Morgan Stanley set a $20.00 price objective on shares of Phibro Animal Health in a report on Tuesday, April 15th. Finally, StockNews.com cut shares of Phibro Animal Health from a "buy" rating to a "hold" rating in a report on Tuesday, March 25th. Two research analysts have rated the stock with a sell rating and three have given a hold rating to the company. Based on data from MarketBeat, Phibro Animal Health currently has a consensus rating of "Hold" and an average price target of $19.75.
Check Out Our Latest Stock Analysis on Phibro Animal Health
Phibro Animal Health Company Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Stories

Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.